Publications

Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

 117
Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

Tags:

Previous Article

Human Schwann cell lipid dysregulation and plasma membrane perturbation in Charc...

Next Article

FerroTerminator1 as a potent therapeutic drug for MASH

Related Posts

Circadian PERIOD proteins regulate TC-DSB repair through anchoring to the nuclear envelope

Circadian PERIOD proteins regulate TC-DSB repair throug...

 83

Social isolation recruits amygdala–medial prefrontal cortex projections to escalate alcohol drinking in male mice

Social isolation recruits amygdala–medial prefrontal co...

 1119

Neural crest precursors from the skin are the primary source of directly reprogrammed neurons

Neural crest precursors from the skin are the primary s...

 146